 |
|
| LEUKEMIA RESEARCH
| |
| | |
|
|
 Clinical and Laboratory Studies
Editors-in-Chief:
John M. Bennett, Terry J. Hamblin
See editorial board for all editors information
Description
Leukemia Research is an international journal which brings comprehensive and current information to
all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other
hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry,
cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.
Specifically, of major interest will
be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics
and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected
articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients
with a wide range of neoplasms.
For more information contact the Myelodysplastic Syndromes Foundation at  http://www.mds-foundation.org/
Bibliographic & ordering information
ISSN: 0145-2126
Imprint: ELSEVIER
Commenced publication 1977
Subscriptions for the year 2009,
Volume 33,
12 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Institutional price: Order form
JPY 382,700 for Japan
USD 3,224 for all countries except Europe, Japan and Iran
EUR 2,883 for European countries and Iran
Personal price: Order form
EUR 373 for European countries and Iran
USD 416 for all countries except Europe, Japan and Iran
JPY 49,300 for Japan
Personal price UK: Order form
GBP 260
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Medical scientists, haematologists, immunologists, oncologists and chemotherapists.
Impact factor of this journal
2007: 2.561
© Journal Citation Reports 2008, published by Thomson Reuters
063/631
Last update: 4 Sep 2008
|
|
| |
| | |
|
|
| |
